onivyde liposomal pégylé 4.3 mg/ml dispersion à diluer pour perfusion
servier (suisse) sa - irinotecanum - dispersion à diluer pour perfusion - irinotecanum 43 mg ut irinotecani sucrosofas corresp. irinotecani hydrochloridum trihydricum 50 mg, 1,2-distearoyl-sn-glycero-3-phosphocholinum, cholesterolum, n-(carbonyl-methoxypolyethylenglycoli 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolaminum natricum, acidum hydroxyethylpiperazinethansulfonicum, natrii chloridum corresp. natrium 33.1 mg, aqua ad iniectabile q.s. ad solutionem pro 10 ml. - adenocarcinomi del pancreas metastatico - synthetika
irinotecan docpharma
docpharma n.v. - irinotecan - irinotecan
irinotecan sandoz
sandoz s.p.a. - irinotecan - irinotecan
irinotecan accord
accord healthcare, s.l.u. - irinotecan - irinotecan
irinotecan sandoz gmbh
sandoz gmbh - irinotecan - irinotecan
irinotecan fresenius
fresenius kabi italia s.r.l. - irinotecan - irinotecan
irinotecan crinos
crinos s.p.a. - irinotecan - irinotecan
irinotecan aurobindo
eugia pharma (malta) limited - irinotecan - irinotecan
irinotecan teva
teva italia s.r.l. - irinotecan - irinotecan
irinotecan kabi
fresenius kabi italia s.r.l. - irinotecan - irinotecan